Celsion CorpAdd to My Watchlist

CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 2.38
    Last
  • 0.04  -1.49%
    Today's Change
  • 2.42
    Previous Close
  • Today
     
    2.30
    4.74
    52 Week Low - High
2:23 pm ET 12/22/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding20 million
Market Cap$48 million
Return on Equity ttm-81.08%
Last DividendCLSN:US does not pay a dividend
Earnings
EPS: Year Actual ttm-1.380
EPS: Year Est. 12/14 ttm-1.425
 
EPS: Quarterly Actual 9/14 -0.35
EPS: Quarterly Est. 12/14 -0.37
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate72.38
Company Description
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Revenue$500,000
Net Income$-8 million
Total Assets$46 million
Employees13
Web Sitewww.celsion.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!